to download the program outline
Dr Ken OngKen Ong leads the Child Growth and Development programme at the MRC Epidemiology Unit, University of Cambridge, UK. His research has identified trajectories of childhood growth, weight gain and pubertal timing as determinants of obesity and related disease, and aims to understand the genetic, epigenetic and endocrine mechanisms that underlie these links. He works closely with the Unit’s other research areas in the aetiology of obesity and type 2 diabetes, and the development and testing of interventions to prevent childhood obesity. As well as his research work, Ken is a consultant paediatric endocrinologist and the clinical lead for childhood obesity at Cambridge University Hospitals NHS Trust. He obtained his PhD following research at the Universities of Oxford and Cambridge, where he studied gene-environment interactions in fetal and early childhood growth in large birth cohort studies.
Elks CE*, Perry JR*, Sulem P*, …… Murabito JM*^, Ong KK*^, Murray A*^. Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nature Genetics. 2010; 42: 1077-85. PMID: 21102462 *joint contributions and ^corresponding authors
Lakshman R, Elks CE, Ong KK. Childhood obesity. Circulation. 2012;126(14): 1770-9. PMID:23027812
Ong KK, Hardy R, Shah I, Kuh D. Childhood stunting and mortality between 36-64 years: the British 1946 Birth Cohort Study. J Clin Endocrinol Metab. 2013; 98: 2070-7. PMID: 23533234
Professor George Werther
Professor George Werther is Director of the Centre for Hormone Research at the Murdoch Childrens Research Institute at the Royal Children’s Hospital (RCH) in Melbourne, where he is also Director of Endocrinology. At RCH, he oversees a busy clinical practice in childhood diabetes and endocrine disorders. He has been involved in clinical and basic research on growth and development for some 30 years, focussing on growth hormone (GH) and the insulin-like growth factor (IGF) system and mechanisms of regulation of the linear growth in both short and tall stature. His recent work examines roles of the IGF system in abnormal growth and cancer, as well as in metabolism and obesity. He was a founding Director of Antisense Therapeutics Limited, a publicly listed biotech company with a strong focus on therapeutic regulation of the GH/IGF system, whose original lead drug came from research in his laboratory. Outside his medical/scientific pursuits, George is active in the theatrical world, having played a variety of characters, both real (Sigmund Freud, CS Lewis, Ludwig Van Beethoven), and imaginary.
Dr Phil Zeitler
Dr. Zeitler is Professor of Pediatrics and Head of the Section of Pediatric Endocrinology at the University of Colorado. He is also Medical Director of the Children’s Hospital Colorado Clinical Translational Research Center of the Colorado Clinical Translational Science Institute, Chair of the Department of Endocrinology at Children’s Hospital Colorado, and director of the Type 2 diabetes and Metabolic Syndrome Programs.
Dr. Zeitler’s research group is interested in understanding the physiologic and psychological aspects of obesity and insulin resistance disorders in adolescents, as well as in type 1 and type 2 diabetes. Dr. Zeitler is Chair of TODAY, an NIH-funded, multi-center trial examining treatment options for adolescents with type 2 diabetes, as well as the TODAY Genetics Study. He is also Co-investigator in RISE, an NIH consortium exploring ways to improve beta cell function in adolescents with prediabetes or recent onset type 2 diabetes.
Dr. Leanne Ward
Dr. Leanne Ward is an Associate Professor of Pediatrics at the University of Ottawa where she holds a Research Chair in Pediatric Bone Health. She is the Medical Director of the Pediatric Bone Health Clinical and Research Programs at the Children’s Hospital of Eastern Ontario and a pediatric endocrinologist within the Division of Endocrinology and Metabolism at CHEO.
Dr. Ward completed her medical degree at McMaster University and her training in Pediatrics at Dalhousie University in Halifax, Nova Scotia. She completed her pediatric endocrinology fellowship at St. Justine Hospital (University of Montreal) and trained with Dr. Francis Glorieux in pediatric metabolic bone diseases at the Shriners Hospital, McGill University before taking up her current position at the University of Ottawa in 2001.
Dr. Ward’s research program is dedicated to the study of bone development and the treatment of bone disorders in children. She is the principal investigator of the “STOPP” research program (STeroid-induced Osteoporosis in the Pediatric Population), a pan-Canadian project funded by the Canadian Institutes of Health Research to evaluate the effect of glucocorticoids on bone health in children with chronic illnesses. Dr. Ward has received a number of awards for her work in pediatric bone health, including a Canadian Child Health Clinician Scientist Career Development Award (2004), a Canadian Institutes for Health Research New Investigator Award (2004) and a Canadian Child Health Clinician Scientist Career Enhancement Award (2007).
Associate Professor Maria Craig
Maria is a Paediatric Endocrinologist and clinician researcher at the Children’s Hospital at Westmead and St George Hospital in Sydney, and a NHMRC Practitioner Fellow (University of Sydney). Her major research focus is childhood diabetes, including the epidemiology and viral aetiology of diabetes. Maria is a former President of APEG and co-chaired the Australian National Evidence Based Clinical Practice Guidelines for Type 1 Diabetes in Children, Adolescents and Adults. She is a co-editor of the ISPAD Clinical Practice Guidelines (2014). She is scientific co-ordinator for the APPES fellows schools and co-convened the APPES CME updates in 2011 and 2013.
Dr Elaine ThamElaine Tham is a Paediatric Endocrinologist at the Women’s and Children’s Hospital Adelaide. She completed a Masters in Medical Science in the area of diabetic retinopathy and undertook further clinical and research training at the British Columbia’s Children’s Hospital in Vancouver, Canada. She is involved in the clinical care of children with diabetes and endocrine disorders with an interest in calcium and bone disorders. She is coordinator of the bisphosphonate program and intranet resources for endocrinology at her local hospital, and is involved in teaching and supervision of trainees.
Dr Peter Simm is a Paediatric Endocrinologist from Melbourne, Australia, with appointments at the Royal Children's Hospital Melbourne and Monash Children's. He undertook postgraduate training in Paediatric Bone and Mineral medicine at Children's Hospital Westmead, Sydney. He continues to have both clinical and research interests in this area, undertaking studies in bone health in epilepsy and osteopenia of prematurity, as well as reporting the bone density scans for RCH. He also has interests in growth disorders and transition of care, particularly in diabetes.
Dr Pik To Cheung
Current appointments
1. Associate Professor, Department of Paediatrics and Adolescent Medicine, The University of Hong Kong
2. Honorary Consultant (Paediatric Services), Hospital Authority, Hong Kong
Past appointments
1. Fellow, Pediatric Endocrinology, Children's Hospital Medical Center, Cincinnati, Ohio, USA (1988-92)
2. Research Associate, Neurochemie Labor, Kinderklinik, Inselspital Bern, Bern, Switzerland (1992-4)
Current professional memberships:
- Council Member, Hong Kong College of Paediatricians
- Chairman, Scientific Programme Committee, Asia-Pacific Pediatric Endocrinology Society (APPES)
- Council Member, Asia-Pacific Pediatric Endocrinology Society
- Member, The Endocrine Society, USA
- Past President, the Hong Kong Society for Paediatric Endocrinology and Metabolism
- Past President, Hong Kong Society of Endocrinology, Metabolism and Reproduction
- Senior Editor, The Hong Kong Medical Journal
- Director, Editorial Board, Journal of Paediatrics, Obstetrics and Gynaecology
- Member, Editorial Board, Chinese Journal of Contemporary Pediatrics
Assoc Prof Dr. Muhammad Yazid Bin Jalaludin
Prof Yazid joined Ministry of Health as a House-officer from June 1997 to Dec 1998 and as a Medical Officer from Dec 1998 to June 2000. He then joined University Malaya as a Trainee Lecturer in 2000 and later as a Lecturer in 2004. In 2007, he was appointed as a Senior Lecturer. He is currently a Consultant Paediatrician and Consultant Paediatric Endocrinologist at the University Malaya Medical Centre (UMMC) who specializes in endocrine and diabetes management in children, and an Assoc Professor at the Faculty of Medicine, University Malaya. For his excellent service, he was awarded Excellence Service Certificate by University Malaya in 2006 and 2010.
He has been a member of various medical societies, including The Endocrine Society USA, International Society for Paediatric and Adolescent Diabetes (ISPAD), Asia Pacific Paediatric Endocrine Society (APPES) and the Malaysian Endocrine and Metabolic Society (MEMS) as well as a life-member of the Malaysian Paediatric Association (MPA). He is currently the Council Member of the Asia Pacific Paediatric Endocrine Society (APPES), the Malaysian Endocrine and Metabolic Society (MEMS) and the Malaysian Paediatric Association (MPA).
With research interest in diabetes, obesity and vitamin D in children, Prof Yazid’s work has been published in various academic journals and as textbook chapters. He has numerous experiences presenting in conferences and workshops locally and abroad. He had previously received Travel Grant Awards to the International Society for Paediatric and Adolescent Diabetes (ISPAD) Meetings in Slovenia (2009), Argentina (2010) and Turkey (2012), and to the Endocrine Society’s 91st Annual Meeting in Washington DC, USA (2009) where he was awarded the winner of the Presidential Poster Presentation. He also won the Best Poster Presentation at the International Society for Paediatric and Adolescent Diabetes (ISPAD) Meeting 2012, in Istanbul, Turkey.
Dr Nalini ShahDr Nalini Samir Shah is Professor & Head, Department of Endocrinology, Seth G S Medical College, K.E.M.Hospital, Parel, Mumbai, India. She is known for her astute clinical judgment and her keen interest in training her post graduates specializing in endocrinology. An academician to the core, she has always been a merit holder with several “first” and gold medals to her credit. She has received training in Paediatric Endocrinology in London Centre for Pediatric Endocrinology.
She heads a busy department known nationally and internationally for the vast clinical experience it offers. She is ideally suited to address the topics assigned for this meeting. She has several publications to her credit in various international journals. She has held several positions of responsibility to her credit. She has been president of Indian Society for Pediatric
and Adolescent Endocrinology.
Dr Sarah McMahon
Sarah McMahon is a Paediatric Endocrinologist at the Royal Children’s Hospital in Brisbane. She completed a PhD at the University of Western Australia looking at glucose requirements after exercise in adolescents with type 1 diabetes. She is involved in the care of children and adolescents with diabetes and all endocrine disorders with an interest in Turner syndrome. She also enjoys teaching and is involved with preparation of candidates for the FRACP clinical examination and is on the National Examining Panel and Clinical Examination Committee of the Royal Australasian College of Physicians.
